Type 2 Diabetes Mellitus Clinical Presentation: History, Physical Examination. Diabetes Care. 3. Suppl 1: S6. 2- 9. Standards of medical care in diabetes- -2. Diabetes Care. 3. Suppl 1: S1. 1- 6. Preventive Services Task Force. Screening for Type 2 Diabetes Mellitus in Adults. Available at http: //www. New EASD/ADA Position Paper Shifts Diabetes Treatment Goals. Medscape Medical News. Available at http: //www. Accessed: October 1. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment.In this article. I have gestational diabetes. Why do I have to watch what I eat? How will I have to change my diet? I've heard about good carbs and bad carbs. The Best Diet Plan is a FREE guide to creating the diet that will best allow you to lose fat, build muscle, and be healthy. Diabetes Mellitus Definition. Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or cells stop responding to the insulin that is. Xultophy 100 units/ml insulin degludec + 3.6 mg/mL liraglutide solution for injection in a pre-filled pen - Summary of Product Characteristics (SPC) by Novo Nordisk. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient- centered approach. We are learning more about diabetes all the time, and it is becoming clear the harder you work to control your diabetes when it is diagnosed the more benefit. Victoza 6 mg/ml solution for injection in pre-filled pen - Summary of Product Characteristics (SPC) by Novo Nordisk Limited. Thiamine Deficiency and Diabetes. The Paradigm Shift. Left Image: Spark Plug of Life which represents the role of thiamine in cellular energy. People with diabetes are frequently given advice about protein that has no scientific basis. In addition, although weight is lost when individuals follow. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 5. 5(6): 1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient- centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 3. New diabetes guidelines ease systolic blood pressure target. December 2. 0, 2. Medscape Medical News. Available at http: //www. Accessed: January 8, 2. American Diabetes Association clinical practice recommendations: 2. Diabetes Care. January 2. S1- S1. 10. Diabetes Care. Suppl 1: S5- 2. 0. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A. Sep 1. 4. 1. 07(3. Department of Health and Human Services, Centers for Disease Control and Prevention, 2. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2. Available at http: //www. Accessed: January 5, 2. Philippe MF, Benabadji S, Barbot- Trystram L, Vadrot D, Boitard C, Larger E. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Bacha F, Lee S, Gungor N, Arslanian SA. From pre- diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 3. Increased postprandial GIP and glucagon responses, but unaltered GLP- 1 response after intervention with steroid hormone, relative physical inactivity, and high- calorie diet in healthy subjects. J Clin Endocrinol Metab. Wheeler E, Barroso I. Genome- wide association studies and type 2 diabetes. Brief Funct Genomics. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci. Nov; 1. 21. 2: 5. The E2. 3K variant of Kir. OGTT serum insulin response and increased risk of type 2 diabetes. Ukkola O, Sun G, Bouchard C. Insulin- like growth factor 2 (IGF2 ) and IGF- binding protein 1 (IGFBP1) gene variants are associated with overfeeding- induced metabolic changes. Diabetologia. 4. 4(1. Lindgren CM, Mc. Carthy MI. Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity. Nat Clin Pract Endocrinol Metab. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome- wide association study identifies novel risk loci for type 2 diabetes. Feb 2. 2. 4. 45(7. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A, et al. Common variants in WFS1 confer risk of type 2 diabetes. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, Mc. Cabe E, et al. Metabolite profiles and the risk of developing diabetes. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Krssak M, Winhofer Y, Gobl C, Bischof M, Reiter G, Kautzky- Willer A, et al. Insulin resistance is not associated with myocardial steatosis in women. Diabetologia. 5. 4(7): 1. Leiter LA, Lundman P, da Silva PM, Drexel H, Junger C, Gitt AK. Persistent lipid abnormalities in statin- treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study. Do non- insulin- dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med. 1. Pt 2): 1. 10- 6. Haffner SM, D'Agostino R Jr, Mykkanen L, Tracy R, Howard B, Rewers M, et al. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2. Gray- matter atrophy may drive cognitive decline in diabetes. Medscape Medical News. August 2. 2, 2. 01. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care. 2. Aug 1. 2. Depression accelerates cognitive decline in type 2 diabetes. Medscape Medical News. October 1. 7, 2. 01. Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD- MIND Trial. JAMA Psychiatry. 7. Appropriate body- mass index for Asian populations and its implications for policy and intervention strategies. Jan 1. 0. 3. 63(9. Wei GS, Coady SA, Goff DC Jr, Brancati FL, Levy D, Selvin E, et al. Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study. Diabetes Care. 3. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care. 2. Yarbrough DE, Barrett- Connor E, Kritz- Silverstein D, Wingard DL. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study. Diabetes Care. 2. Li Y, Qi Q, Workalemahu T, Hu FB, Qi L. Birth Weight, Genetic Susceptibility, and Adulthood Risk of Type 2 Diabetes. Diabetes Care. 2. Aug 2. 4. Slining MM, Kuzawa CW, Mayer- Davis EJ, Adair LS. Evaluating the indirect effect of infant weight velocity on insulin resistance in young adulthood: a birth cohort study from the Philippines. Am J Epidemiol. 2. Mar 1. 5. 1. 73(6): 6. Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of Cancer (EPIC)- Norfolk Study. Diabetes Care. 3. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia. 5. 4(6): 1. Genetic risk reclassification for type 2 diabetes by age below or above 5. Diabetes Care. 3. Evaluation of common variants in the six known maturity- onset diabetes of the young (MODY) genes for association with type 2 diabetes. Molven A, Ringdal M, Nordbo AM, Raeder H, Stoy J, Lipkind GM, et al. Mutations in the insulin gene can cause MODY and autoantibody- negative type 1 diabetes. Neve B, Fernandez- Zapico ME, Ashkenazi- Katalan V, Dina C, Hamid YH, Joly E, et al. Role of transcription factor KLF1. Proc Natl Acad Sci U S A. Mar 2. 9. 1. 02(1. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Plengvidhya N, Kooptiwut S, Songtawee N, Doi A, Furuta H, Nishi M, et al. PAX4 mutations in Thais with maturity onset diabetes of the young. J Clin Endocrinol Metab. Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, et al. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta- cell dysfunction. Proc Natl Acad Sci U S A. Aug 2. 5. 1. 06(3. Mutations in hepatocyte nuclear factor- 1beta and their related phenotypes. J Med Genet. 4. 3(1): 8. Mutation in mitochondrial t. RNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Castellino AM. Genetically Lowered Birth Weight May Cause Type 2 Diabetes. Medscape Medical News. July 4, 2. 01. 6. Low birthweight and risk of type 2 diabetes: a Mendelian randomisation study. Diabetologia. 2. 01. Jun 2. 3. Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2. Nov 2. 2. 1. 70(2. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta- analysis. Diabetologia. 5. 3(1. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia- like behaviors in neuronal rictor null mice. Preeclampsia as a risk factor for diabetes: a population- based cohort study. American Adults Will Develop Diabetes. Medscape Medical News. Available at http: //www. Accessed: August 1. Gregg EW, Zhuo X, Albright AL, et al. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1. The Lancet Diabetes & Endocrinology. Available at http: //www. PIIS2. 21. 3- 8. 58. Accessed: August 1. Ludwig J, Sanbonmatsu L, Gennetian L, Adam E, Duncan GJ, Katz LF, et al. Neighborhoods, obesity, and diabetes- -a randomized social experiment. N Engl J Med. 2. 01. Oct 2. 0. 3. 65(1. One adult in ten will have diabetes by 2. International Diabetes Federation. November 1. 4, 2. Available at http: //www. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross- sectional analysis of community- based data. Ann Intern Med. 1. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 3. Effect of prior intensive therapy in type 1 diabetes on 1. DCCT/EDIC: comparison of adults and adolescents. UK Prospective Diabetes Study (UKPDS) Group. Sep 1. 2. 3. 52(9. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE. Effect of regression from prediabetes to normal glucose regulation on long- term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Jun 1. 6. 3. 79(9. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. N Engl J Med. 3. 59(1. Dluhy RG, Mc. Mahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2. 00. Jun 1. 2. 3. 58(2. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |